Reckitt Benckiser Group plc (RKT)

Basic

  • Market Cap

    £36.62B

  • EV

    £43.79B

  • Shares Out

    711.97M

  • Revenue

    £14.61B

  • Employees

Margins

  • Gross

    59.97%

  • EBITDA

    31.22%

  • Operating

    22.93%

  • Pre-Tax

    16.44%

  • Net

    11.25%

  • FCF

    15.66%

Returns (5Yr Avg)

  • ROA

    6.57%

  • ROTA

    -5.01%

  • ROE

    5.55%

  • ROCE

    14.44%

  • ROIC

    8.06%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    £61.77

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    £1,387M

  • Net Debt

    £7,150M

  • Debt/Equity

    1.01

  • EBIT/Interest

    11.35

Growth (CAGR)

  • Rev 3Yr

    1.44%

  • Rev 5Yr

    3.01%

  • Rev 10Yr

    4.66%

  • Dil EPS 3Yr

    12.6%

  • Dil EPS 5Yr

    -5.72%

  • Dil EPS 10Yr

    1.69%

  • Rev Fwd 2Yr

    1.82%

  • EBITDA Fwd 2Yr

    -0.47%

  • EPS Fwd 2Yr

    0.32%

  • EPS LT Growth Est

    21.04%

Dividends

  • Yield

  • Payout

    84.43%

  • DPS

    £1.93

  • DPS Growth 3Yr

    3.31%

  • DPS Growth 5Yr

    2.43%

  • DPS Growth 10Yr

    3.46%

  • DPS Growth Fwd 2Yr

    4.33%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

Total Revenues

12,846

13,993

13,234

14,453

14,607

Total Revenues % Chg.

2%

8.9%

-5.4%

9.2%

1.1%

Cost of Goods Sold, Total

5,068

5,558

5,544

6,092

5,847

Gross Profit

7,778

8,435

7,690

8,361

8,760

Selling General & Admin Expenses, Total

4,365

5,004

4,650

4,643

-8

R&D Expenses

257

288

313

325

Other Operating Expenses

-3

-7

-3

-22

5,419

Other Operating Expenses, Total

4,619

5,285

4,960

4,946

5,411

Operating Income

3,159

3,150

2,730

3,415

3,349

Interest Expense, Total

-331

-276

-244

-233

-295

Interest And Investment Income

96

61

29

29

41

Net Interest Expenses

-235

-215

-215

-204

-254

Income (Loss) On Equity Invest.

-1

-3

-2

Currency Exchange Gains (Loss)

-5

764

32

151

Other Non Operating Income (Expenses)

85

-71

-4

-2

-35

EBT, Excl. Unusual Items

3,009

2,858

3,272

3,239

3,211

Restructuring Charges

Merger & Related Restructuring Charges

-14

Impairment of Goodwill

-5,116

-985

-167

-810

Gain (Loss) On Sale Of Investments

-19

Gain (Loss) On Sale Of Assets

-3,518

14

Asset Writedown

Other Unusual Items

EBT, Incl. Unusual Items

-2,107

1,873

-260

3,067

2,401

Income Tax Expense

665

720

-208

711

753

Earnings From Continuing Operations

-2,772

1,153

-52

2,356

1,648

Earnings Of Discontinued Operations

-898

50

31

-7

9

Minority Interest

-13

-16

-11

-19

-14

Net Income

-3,683

1,187

-32

2,330

1,643

Net Income to Common Incl Extra Items

-3,683

1,187

-32

2,330

1,643

Net Income to Common Excl. Extra Items

-2,785

1,137

-63

2,337

1,634

Total Shares Outstanding

709.7

712.7

714.4

715.8

716.9

Weighted Avg. Shares Outstanding

708.7

710.9

713.8

715.3

716.7

Weighted Avg. Shares Outstanding Dil

708.7

713.7

713.8

717.5

718.3

EPS

-5.2

1.7

-0

3.3

2.3

EPS Diluted

-5.2

1.7

-0

3.2

2.3

EBITDA

3,560

3,485

3,093

3,784

4,560